With a new tool called Mobile Apps by Replit, users can describe their idea, let Replit do its thing, and then test the app ...
Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...